Posted 3 years ago | by Bethany Armstrong
Health and medical industries are implementing blockchain technology across the globe.
Over the summer, The Food and Drug Administration (FDA) launched a pilot program utilizing blockchain technology for pharmaceutical purposes. IBM, Walmart, Merck, and KPMG collaborated with the FDA to test the the blockchain. The pilot program is designed to conclude in the last quarter of 2019.
The outcome results of this project will be looking for how well the blockchain technology program helped track, identify, and trace medical prescriptions. The FDA is also considering the level efficiency and security measures using the blockchain technology. With the growing epidemic of prescription drug and illicit drug abuse, The National Drug Abuse reports that in 2017, over 70,000 Americans died from drug abuse. Implementing blockchain technology has the potential to track, trace, and identify safety measures for prescription drugs.
The FDA is also considering using blockchain technology for food safety concerns. FDA Deputy Commissioner Frank Yiannas indicated that the pursuit of blockchain technology is not because it is “cool technology”, but because it provides transparency and traceability for identifying the source of unsafe food. The E.coli lettuce outbreak of November 2018 served as the catalyst for looking for a better option for insuring food safety. The ability to quickly identify the source of unsafe food and protect more people.
Brazil became the first country to issue a birth certificate for a newborn on a blockchain technology. This is a significant milestone in blockchain history.
In three steps, the birth certificate was issued: step one, confirm live birth at hospital; step two, parents create a digital identity for the baby; step three, the collected information is sent to a notary’s office. The notary was done by Notary Ledger platform of Growth Trust. Notary Ledger platform includes virtual notary services.